Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2000;21(1):1–6. doi: 10.1385/IR:21:1:1

Peroral immunotheraphy with yolk antibodies for the prevention and treatment of enteric infections

David Carlander 1, Hans Kollberg 2, Per-Erik Wejåker 1, Anders Larsson 1
PMCID: PMC7090601  PMID: 10803878

Abstract

Oral administration of specific antibodies is an attractive approach to establish protective immunity against gastrointestinal pathogens in humans and animals. The increasing number of antibiotic-resistant bacteria emphasize the need to find alternatives to antibiotics. Immunotherapy can also be used against pathogens that are difficult to treat with traditional antibiotics.

Laying hens are very good producers of specific antibodies. After immunization, the specific antibodies are transported to the egg yolk from which the antibodies then can be purified. A laying hen produces more than 20 g of yolk antibodies (IgY) per year. These antibodies also have biochemical properties that make them attractive for peroral immunotherapy: They neither activate mammalian complement nor interact with mammalian Fc receptors that could mediate inflammatory response in the gastrointestinal tract. Eggs are also normal dietary components and thus there is practically no risk of toxic side effects of IgY. Yolk antibodies have been shown in several studies to prevent bacterial and viral infections.

Key Words: Antibody, Chicken, Egg, Immunoglobulin, Yolk, Review

References

  • 1.Larsson A, Bålöw R-M, Lindahl TL, Forsberg P-O. Chicken IgG: Utilizing the evolutionary advantage. Poultry Science. 1993;72:1807–1812. doi: 10.3382/ps.0721807. [DOI] [PubMed] [Google Scholar]
  • 2.Bartz CR, Conklin RH, Tunstall CB, Steele JH. Prevention of murine rotavirus infection with chicken egg yolk immunoglobulins. J Infect Dis. 1980;242:439–441. doi: 10.1093/infdis/142.3.439. [DOI] [PubMed] [Google Scholar]
  • 3.Hamada S, Horikoshi T, Minami T, Kawabata S, Hiraoka J, Fujiwara T, Ooshima T. Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect Immun. 1991;59:4161–4167. doi: 10.1128/iai.59.11.4161-4167.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hatta H, Tsuda K, Ozeki M, Kim M, Yamamoto T, Otake S, Hirasawa M, Katz J, Childers NK, Michalek SM. Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Cancer Res. 1997;31:268–274. doi: 10.1159/000262410. [DOI] [PubMed] [Google Scholar]
  • 5.Kuroki M, Ohta M, Ikemori Y, Peralta RC, Yokoyama H, Kodama Y. Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk. Arch Virol. 1994;138:143–148. doi: 10.1007/BF01310045. [DOI] [PubMed] [Google Scholar]
  • 6.Leslie GA, Clem LW. Chicken immunoglobulins: biological halflives and normal adult serum concentrations of IgM and IgY. Proc Soc Exp Biol Med. 1970;134:195–198. doi: 10.3181/00379727-134-34758. [DOI] [PubMed] [Google Scholar]
  • 7.Schade R, Staak C, Hendriksen C, Erhard M, Hugl H, Koch G, Larsson A, Pollmann W, Regenmortel M, Rijke E, Spielmann H, Steinbusch H, Straughan D. The production of avian (egg yolk) antibodies: IgY. ATLA. 1996;24:925–934. [Google Scholar]
  • 8.Hilpert H, Brussow H, Mietens C, Sidoti J, Lerner L, Werchau H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis. 1987;156:158–166. doi: 10.1093/infdis/156.1.158. [DOI] [PubMed] [Google Scholar]
  • 9.Losonsky GA, Johnson JP, Winkelstein JA, Yolken RH. Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokientic and functional analysis. J Clin Invest. 1985;76:2362–2367. doi: 10.1172/JCI112248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yokoyama H, Peralta RC, Sendo S, Ikemori Y, Kodama Y. Detection of passage and absorption of chicken egg yolk immunoglobulins in the gastrointestinal tract of pigs by use of enzyme-linked immunosorbent assay and fluorescent antibody testing. Am J Vet Res. 1993;54:867–872. [PubMed] [Google Scholar]
  • 11.Blum PM, Phelps DL, Ank BJ, Krantman HJ, Stiehm ER. Survival of oral human immune serum globulin in the gastrointestinal tract of low birth weight infants. Pediatr Res. 1981;15:1256–1260. doi: 10.1203/00006450-198109000-00006. [DOI] [PubMed] [Google Scholar]
  • 12.Eibl MM, Wolf HM, Furnkranz H, Rosenkranz A. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med. 1988;319:1–7. doi: 10.1056/NEJM198807073190101. [DOI] [PubMed] [Google Scholar]
  • 13.Bernhisel-Broadbent J, Yolken RH, Sampson HA. Allergenicity of orally administered immunoglobulin preparations in food-allergic children. Pediatrics. 1991;87:208–214. [PubMed] [Google Scholar]
  • 14.Yokoyama H, Peralta RC, Umeda K, Hashi T, Icatlo FC, Jr, Kuroki M, Ikemori Y, Kodama Y. Prevention of fatal salmonellosis in neonatal calves, using orally administered chicken egg yolk Salmonellaspecific antibodies. Am J Vet Res. 1998;59:416–420. [PubMed] [Google Scholar]
  • 15.Peralta RC, Yokoyama H, Ikemori Y, Kuroki M, Kodama Y. Passive immunisation against experimental salmonellosis in mice by orally administered hen egg-yolk antibodies specific for 14-kDA fimbriae of Salmonella enteritidis. J Med Microbiol. 1994;41:29–35. doi: 10.1099/00222615-41-1-29. [DOI] [PubMed] [Google Scholar]
  • 16.Yokoyama H, Peralta RC, Diaz R, Sendo S, Ikemori Y, Kodama Y. Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets. Infect Immun. 1992;60:998–1007. doi: 10.1128/iai.60.3.998-1007.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.O'Farrelly C, Branton D, Wanke CA. Oral ingestion of egg yolk immunoglobulin from hens immunized with an enterotoxigenic Escherichia coli strain prevents diarrhea in rabbits challenged with the same strain. Infect Immun. 1992;60:2593–2597. doi: 10.1128/iai.60.7.2593-2597.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Carlander D, Kollberg H, Wejåker PE, Larsson A. Prevention of chronic pseudomonas aeruginosa colonisation by gargling with specific antibodies. Wallingford, Oxon, UK.: CAB International; 1999. [Google Scholar]
  • 19.Ikemori Y, Ohta M, Umeda K, Icatlo FC, Jr, Kuroki M, Yokoyama H, Kodama Y. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Vet Microbiol. 1997;58:105–111. doi: 10.1016/S0378-1135(97)00144-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kuroki M, Ohta M, Ikemori Y, Icatlo FC, Jr, Kobayashi C, Yokoyama H, Kodama Y. Field evaluation of chicken egg yolk immunoglobulins specific for bovine rotavirus in neonatal calves. Arch Virol. 1997;142:843–851. doi: 10.1007/s007050050123. [DOI] [PubMed] [Google Scholar]
  • 21.Kuroki M, Ikemori Y, Yokoyama H, Peralta RC, Icatlo FC, Jr, Kodama Y. Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk. Vet Microbiol. 1993;37:135–146. doi: 10.1016/0378-1135(93)90188-D. [DOI] [PubMed] [Google Scholar]
  • 22.Ebina T, Tsukada K, Umezu K, Nose M, Tsuda K, Hatta H, Kim M, Yamamoto T. Gastroenteritis in suckling mice caused by human rotavirus can be prevented with egg yolk immunoglobulin (IgY) and treated with a proteinbound poly-saccharide preparation (PSK) Micro-biol Immunol. 1990;34:617–629. doi: 10.1111/j.1348-0421.1990.tb01037.x. [DOI] [PubMed] [Google Scholar]
  • 23.Davidson GP, Whyte PB, Daniels E, Franklin K, Nunan H, McCloud PI, Moore AG, Moore DJ. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet. 1989;2:709–712. doi: 10.1016/S0140-6736(89)90771-X. [DOI] [PubMed] [Google Scholar]
  • 24.Cama VA, Sterling CR. Hyperimmune hens as a novel source of anti-Cryptosporidum antibodies suitable for passiveimmune transfer. J Protozool. 1991;38:42S–43S. [PubMed] [Google Scholar]
  • 25.Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis. 1998;26:1324–1329. doi: 10.1086/516374. [DOI] [PubMed] [Google Scholar]

Articles from Immunologic Research are provided here courtesy of Nature Publishing Group

RESOURCES